
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of SCYNEXIS (NASDAQ:SCYX) through any online brokerage.
Other companies in SCYNEXIS’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
SCYNEXIS has a consensus price target of $33.00.
The stock price for SCYNEXIS (NASDAQ: SCYX) is $4.0897 last updated October 9, 2026 at 6:20 PM EDT.
There are no upcoming dividends for SCYNEXIS.
SCYNEXIS does not have any upcoming earnings scheduled.
There is no upcoming split for SCYNEXIS.
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and...